Cargando…
COX-2 in the neurodegenerative process of Parkinson's disease
The enzyme cyclooxygenase-2 (COX-2), responsible for the first committed step in the synthesis of several important mediators which are involved in both initiation and resolution of inflammation, and the subsequent generation of prostaglandins (PGs) upon activation has been shown to participate in t...
Autor principal: | Teismann, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563218/ https://www.ncbi.nlm.nih.gov/pubmed/22826171 http://dx.doi.org/10.1002/biof.1035 |
Ejemplares similares
-
Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012) -
Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010) -
MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress
por: Hsieh, Ya-Ching, et al.
Publicado: (2011) -
Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review
por: Morowitz, Jeremy M., et al.
Publicado: (2022) -
Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
por: Tassone, Annalisa, et al.
Publicado: (2023)